Early research (Phase 1)Study completedNCT00953758What this trial is testingPF-04449913 In Select Hematologic MalignanciesWho this might be right forHematologic Malignancies Pfizer 47
Testing effectiveness (Phase 2)Study completedNCT01789255What this trial is testingVorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT01532635What this trial is testingA Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched RelativesWho this might be right forHematologic MalignancyLeukemiaAcute Lymphoblastic Leukemia+9 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4
Testing effectiveness (Phase 2)Ended earlyNCT00415909What this trial is testingTALL-104 and Gleevec in Chronic Myelogenous Leukemia PatientsWho this might be right forChronic Myelogenous Leukemia M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00858806What this trial is testingIntermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib TherapyWho this might be right forChronic Myeloid Leukemia Università degli Studi di Brescia 78
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT01220648What this trial is testingDetermining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)Who this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 4
Post-approval studies (Phase 4)UnknownNCT04155411What this trial is testingDose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CPWho this might be right forDasatinibBCR-ABLChronic Myeloid Leukemia Shenzhen Second People's Hospital 65
Early research (Phase 1)Study completedNCT00005064What this trial is testingPS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic SyndromeWho this might be right forAdult Acute Promyelocytic Leukemia (M3)Blastic Phase Chronic Myelogenous LeukemiaPreviously Treated Myelodysplastic Syndromes+5 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT02991898What this trial is testingAdoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more Masonic Cancer Center, University of Minnesota 3
Not applicableWithdrawnNCT02421926What this trial is testingExtension Study of IDEAL (Imatinib) for Chronic Myelgenous Leukemia (CML)Who this might be right forLeukemia, Myelogenous, Chronic, BCR-ABL Positive Asan Medical Center
Not applicableWithdrawnNCT01650467What this trial is testingImatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl PolymorphismsWho this might be right forLeukemia, Myeloid, Chronic-Phase Centre Hospitalier Universitaire de Nīmes
Early research (Phase 1)Ended earlyNCT01426334What this trial is testingDasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib MesylateWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia+1 more National Cancer Institute (NCI) 4
Large-scale testing (Phase 3)Looking for participantsNCT03459534What this trial is testingThe Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIsWho this might be right forChronic Myeloid Leukemia, Chronic PhaseCML, Chronic PhaseCML, Refractory+1 more Il-Yang Pharm. Co., Ltd. 173
Testing effectiveness (Phase 2)Study completedNCT04191187What this trial is testingReduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBiphenotypic Acute Leukemia+15 more H. Lee Moffitt Cancer Center and Research Institute 34
Early research (Phase 1)Study completedNCT01607892What this trial is testingSafety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological CancerWho this might be right forHematological Malignancies Karyopharm Therapeutics Inc 286
Testing effectiveness (Phase 2)Looking for participantsNCT03683433What this trial is testingEnasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene MutationWho this might be right forAcute Bilineal LeukemiaAcute Biphenotypic LeukemiaChronic Myelomonocytic Leukemia+4 more M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00750659What this trial is testingNilotinib Pre and Post Allogeneic Stem Cell TransplantationWho this might be right forChronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaStem Cell Transplantation Sheba Medical Center 24
Testing effectiveness (Phase 2)Ended earlyNCT00531310What this trial is testingReduced Intensity AlloSCT in(CML) With Persistent DiseaseWho this might be right forChronic Myeloid Leukemia Columbia University 5
Testing effectiveness (Phase 2)Study completedNCT02092324What this trial is testingRuxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid LeukemiaWho this might be right forAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Neutrophilic Leukemia OHSU Knight Cancer Institute 51